Telomir Pharmaceuticals TELO 深 沪
等待开盘 08-01 09:30:00 美东时间
1.87
-0.090
-4.59%
华盛通- 最 高2.00
- 今 开1.935
- 成交量 60.05万股
- 最 低 1.86
- 昨 收 1.96
- 总市值 5565.62万
- 52周最高 8.40
- 市盈率 静 --
- 换手率 2.02%
- 52周最低 1.12
- 委 比 -90.65%
- 总股本 2976.27万
- 历史最高 20.72
- 量 比 0.44
- 振 幅 7.14%
- 历史最低 1.12
- 每 手 1
- 风险率 1.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 duri...
07-18 20:07
Market-Moving News for July 18th
TELO: 200% | Telomir Pharmaceuticals Announced Earlier, Data Show Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and
07-18 19:13
Telomir Pharmaceuticals Announced Earlier, Data Show Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
On July 17, 2025, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) reported new preclinical results evaluating the effects of its lead candidate, Telomir-1, in a murine xenograft model using PC3 human prostate
07-18 08:03
Telomir Pharmaceuticals Reveals Promising Preclinical Cancer Results
Telomir Pharmaceuticals, Inc. ( ($TELO) ) has shared an announcement. On July 1...
07-18 04:37
Telo Genomics to Contest Former President’s Lawsuit
The latest announcement is out from Telo Genomics Corp ( ($TSE:TELO) ). Telo Ge...
07-01 07:02
Telomir Pharmaceuticals Reports Positive Preclinical Data
An update from Telomir Pharmaceuticals, Inc. ( ($TELO) ) is now available. On J...
06-18 21:53
Telo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
An update from Telo Genomics Corp ( ($TSE:TELO) ) is now available. Telo Genomi...
06-18 21:08
EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria
Telomir-1 improved cell survival, reduced oxidative stress, and restored mitochondrial balance in preclinical progeria study.
06-18 21:00
Telomir Pharmaceuticals Announces Promising Preclinical Results
The latest update is out from Telomir Pharmaceuticals, Inc. ( ($TELO) ). On Jun...
06-11 21:59
EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder
Telomir-1 boosted telomere length, restored weight and muscle, and cut oxidative stress in a preclinical Werner Syndrome animal model.
06-05 19:41
